CIBC Bancorp USA’s CG Oncology CGON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$558K Buy
7,296
+3,222
+79% +$237K ﹤0.01% 1306
2026
Q2
$331K Buy
4,074
+1,100
+37% +$71.9K ﹤0.01% 1485
2026
Q1
$235K Buy
+2,974
New +$169K ﹤0.01% 1535
2025
Q3
$240K Buy
+5,957
New +$173K ﹤0.01% 1187

Other funds holding CGON

CIBC Bancorp USA's CGON Position: Q3 2026 in Review

CIBC Bancorp USA increased its CG Oncology (CGON) stake by 79% in Q3 2026, buying an estimated $237K and bringing the position to 7,296 shares worth $558K. The position accounts for ﹤0.01% of the portfolio, ranked #1306.

CIBC Bancorp USA first reported a position in CGON in Q3 2025 and has held it in 4 quarters since. 233 funds tracked by Wall St. Rank hold CGON as of Q3 2026.

  • CIBC Bancorp USA held 7,296 shares of CG Oncology worth $558K as of Q3 2026.
  • CIBC Bancorp USA bought 3,222 CG Oncology shares in Q3 2026, an estimated $237K.
  • CG Oncology made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q3 2026, its #1306 holding.
  • CIBC Bancorp USA first reported a position in CG Oncology in Q3 2025 and has held it in 4 quarters since.
  • 233 funds tracked by Wall St. Rank held CG Oncology as of Q3 2026.

Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.